BIO-RAD LABORATORIES, INC. (BIO.B) Shareholders’ equity 2016–2025
BIO-RAD LABORATORIES, INC. (BIO.B) shareholders’ equity at each fiscal year-end, per SEC filings.
$7.5BFY2025 · since FY2016: $2.6B → $7.5B
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $7.5B | +13.5% |
| FY2024 | $6.6B | -24.8% |
| FY2023 | $8.7B | -9.1% |
| FY2022 | $9.6B | -29.7% |
| FY2021 | $13.7B | +38.4% |
| FY2020 | $9.9B | +71.8% |
| FY2019 | $5.8B | +43.2% |
| FY2018 | $4.0B | +37.2% |
| FY2017 | $2.9B | +13.6% |
| FY2016 | $2.6B | — |
Source: SEC XBRL filings · For reference only · Not investment advice